Sampre Nutritions Ltd Q1 FY26 – From Cadbury’s Candy Sidekick to FCCB-Fuelled Sugar Rush, This Toffee Maker is Suddenly the Market’s Choco-Bomb
1. At a Glance
Sampre Nutritions Ltd, a tiny confectionery player from Hyderabad incorporated in 1991, suddenly looks like a penny-stock-turned-candy-crush story. With a market cap of ₹260 Cr and stock price at ₹124 (up nearly 400% in 6 months), it’s now the favorite sweet shop of Dalal Street gossip.
The company sells toffees, candies, eclairs, and does exclusive contract manufacturing of Eclairs for Mondelez India (Cadbury). FY25 sales were a modest ₹31.5 Cr, but losses were ₹–6.85 Cr. ROE is –12.7%, ROCE –7.1%, and operating margins –11%.
So how does a company with a negative PAT, low promoter holding (12.1%), and shrinking equity base suddenly become a multi-bagger? Answer: hype, hope, and a bit of bonus–split–FCCB jalebi swirl.
2. Introduction
Picture this: you’re a small-cap auditor investigating a company that makes toffees and candies. You expect to find dusty books, sticky ledgers, and some free sample éclairs on the desk. Instead, you find announcements about FCCBs, preferential allotments, bonus issues, tie-ups with Perfetti Van Melle, and PRAN Beverages.
This isn’t your average mithai shop—it’s more like a roadside gola stand suddenly claiming to become the next Nestlé.
The Mondelez partnership (Cadbury Eclairs, caramel lollypops) is their credibility badge. Every quarter, that’s the first line in the “About Us” section, because without Cadbury, nobody would take them seriously. But beyond Cadbury, Sampre is trying to get into nutraceuticals, international supply contracts, and mega fund raises—basically reinventing itself as a “nutrition” play, not just “toffee waala.”
Question for you: if Cadbury sneezes tomorrow, will Sampre catch pneumonia? Or is this truly the sweet turnaround story it looks like?
3. Business Model – WTF Do They Even Do?
Sampre makes sugar-based confectionery. The product list sounds like a birthday return-gift bag: Just Coffy, Creem Zone, Candy Nutri, éclairs, fruit-flavored toffees.
But the real money comes from job work, not branded sales:
FY21 revenue split: ~22% sales, ~78% job work.
Translation: “We don’t sell much under our brand, we mostly make toffees for other people.”
Exclusive contract: Mondelez India (Cadbury). Sampre manufactures all their éclairs for domestic + export. If you’ve eaten a Cadbury Eclairs in the last 5 years, congratulations, you’ve indirectly tasted Sampre’s work.
Recent capex: Mondelez ordered Sampre to add a caramel lollypop line. For this, Sampre invested ₹2.5 Cr to add 350 TPA capacity. Basically, Cadbury says “jump,” Sampre buys machinery and replies “how high?”
So what’s the business model? Answer: low-margin job-work confectionery factory with Cadbury as landlord, and now flirting with nutraceuticals via Tolaram Wellness.
4. Financials Overview
Here’s the latest quarterly scorecard (Q1 FY26):
Source table
Metric
Latest Qtr (Q1 FY26)
YoY Qtr (Q1 FY25)
Prev Qtr (Q4 FY25)
YoY %
QoQ %
Revenue
10.9 Cr
4.5 Cr
7.8 Cr
+141%
+40%
EBITDA
1.4 Cr
1.1 Cr
–6.3 Cr
+27%
Swing
PAT
0.71 Cr
–0.54 Cr
–7.14 Cr
+184%
Positive
EPS (₹)
0.34
–0.30
–3.40
Green
Green
Commentary: After 4 quarters of sticky losses, they suddenly reported profit. Investors reacted like kids at a birthday party—sugar high rally, 200% in 3 months. But one quarter of profit does not a chocolate empire make.
